Abiopharma

🔍 Da Cunha Gustavo Werneck (Executive)

Company: GERDAU S.A. (GGB)

Report Date: 2026-04-28

Detailed Transactions and Holdings:

• Sold 88,000 shares of Preferred shares at $4.5 per share (Direct)
  Date: 2026-04-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 80.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 86,455 shares of Restricted Stock Units at $3.84 per share (Derivative)
  Date: 2026-04-28 | Code: H | Expires: 2027-02-12 | Exercise: 2027-02-12 | shares_owned_after: 86,455.00 | Footnotes: F2
• Holds 152,887 shares of Restricted Stock Units at $3.73 per share (Derivative)
  Date: 2026-04-28 | Code: H | Expires: 2027-09-01 | Exercise: 2027-09-01 | shares_owned_after: 152,887.00 | Footnotes: F2
• Holds 92,024 shares of Restricted Stock Units at $3.6 per share (Derivative)
  Date: 2026-04-28 | Code: H | Expires: 2028-02-12 | Exercise: 2028-02-12 | shares_owned_after: 92,024.00 | Footnotes: F2
• Holds 86,598 shares of Restricted Stock Units at $4.1 per share (Derivative)
  Date: 2026-04-28 | Code: H | Expires: 2029-02-12 | Exercise: 2029-02-12 | shares_owned_after: 86,598.00 | Footnotes: F2

Footnotes:

• F1: The price is denominated in Brazilian reais and has been translated into U.S. dollars at the April 28, 2026 selling rate of R$4.9878 per US$1.00, as reported by the Central Bank of Brazil.
• F2: The price is denominated in Brazilian reais and has been translated into U.S. dollars at the April 9, 2026 selling rate of R$5.0821 per US$1.00, as reported by the Central Bank of Brazil.